Get an alert when FISONS LIMITED files next

Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.

Free · confirmation link first · unsubscribe in one click

Next accounts due

2026-09-30 (in 4mo)

Last filed for 2024-12-31

Confirmation statement due

2027-01-14 (in 8mo)

Last made up 2025-12-31

Watchouts

None on the register

Cash

Latest balance sheet

Net assets

£14M

+30.3% vs 2023

Employees

0

Average over period

Profit before tax

£4M

-10.2% vs 2023

Name history

Renamed 1 time since incorporation

  1. FISONS LIMITED 1997-12-19 → present
  2. FISONS PLC 1895-07-23 → 1997-12-19

Accounts

2-year trend · latest reflected 2024-12-31

Metric Trend 2023-12-312024-12-31
Turnover £167,000£26,000
Operating profit £1,034,000£28,000
Profit before tax £4,841,000£4,348,000
Net profit £3,702,000£3,261,000
Cash
Total assets less current liabilities £10,751,000£14,012,000
Net assets £10,751,000£14,012,000
Equity £10,751,000£14,012,000
Average employees 00
Wages

Values shown as filed in the company's annual accounts. indicates the figure wasn't present under that line item in that period. About these numbers

Ratios

Computed from the line items above — sparklines read oldest → newest

Ratio Trend 2023-12-312024-12-31
Operating margin 619.2%107.7%
Net margin 2216.8%12542.3%
Return on capital employed 9.6%0.2%
Current ratio 1.04x1.19x

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Audit & accounting basis

Accounting basis
FRS 101
Reporting scope
Standalone (parent only)
Auditor
Forvis Mazars LLP
Audit opinion
Unqualified (clean)
Going concern
Affirmed

“The company is in a net asset position of £14.0m and made a profit of £3.2m. Having considered the plans in place and having reviewed cashflow forecasts, the directors consider the adoption of the going concern basis on preparing these financial statements is appropriate. Furthermore, the Directors have received confirmation from Sanofi S.A. ("Sanofi"), the ultimate parent company, confirming their ability to support the Company to 31 December 2026.”

Significant events

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

People

2 active · 58 resigned

Name Role Appointed Born Nationality
MOHAMED, Walaa Mostafa Abbas Awad Director 2026-02-01 Oct 1977 Egyptian
MOUSSA, Ahmed Mohamed Moustafa Director 2026-02-01 Aug 1984 Egyptian
Show 58 resigned officers
Name Role Appointed Resigned
BAILEY, John Michael Secretary 1995-04-25
CLAPHAM, Christopher Edward Secretary 2000-02-18 2001-06-30
HARRIS, Michael John Secretary 1996-03-31 1996-10-04
MCCLELLAN, Michael James Secretary 2008-02-13 2010-05-12
NICHOLLS, David John Secretary 2001-06-30 2004-12-20
NICHOLLS, David John Secretary 1996-10-04 2000-02-18
ROBERTS, Helen Secretary 2004-12-20 2008-01-30
SMITH, Christopher Secretary 1995-04-25 1996-03-31
SMITH, Suzanne Elaine Secretary 2004-02-23 2004-12-20
ABREHART, David Charles Director 1999-10-01 2000-01-13
ALLINGTON, Timothy James Director 1995-10-23 1998-05-20
AULAGNON, Marie-Christine Gisele Director 1997-04-07 1999-10-01
BAILEY, John Michael Director 1993-12-12 1996-06-30
BAIRD, Jessamy Rachel Director 2021-08-19 2024-03-01
BODMER, Walter, Sir Director 1996-03-31
BRADFORD, Peter Marshall Joseph Director 1996-03-31 2000-01-12
BROOKSBY, Nigel Stanley Director 2005-07-01 2010-05-12
CAWTHORN, Robert Elston Director 1995-10-23 1996-05-30
CHANCEL, Pierre Director 2004-05-19 2009-06-04
CHAPPELL, Edwin Philip Director 1993-01-26
COCCA, Maurice Armand Director 1993-12-12 1995-10-17
COLQUHOUN, Richard Lyons Director 1995-10-23 1997-12-04
DE FORCEVILLE, Guillaume Adrien Director 2005-07-01 2007-11-16
DUHALDE, Francois-Xavier Director 2016-04-01 2021-03-31
EGAN, Patrick Valentine Martin Director 1994-10-31
FRY, Hugo Rupert Alexander Director 2018-10-02 2021-03-31
HANKINSON, David Roger Lindon Director 1994-03-21 1995-11-30
HARRIS, Michael John Director 1996-03-31 1996-10-04
HARRIS OF PECKHAM, Philip Charles, Lord Director 1994-12-31
HEMINGWAY, Roger Barry Director 1998-05-18 2000-03-24
JOHNSON, Peter, Dr Director 1993-02-25 1995-05-30
JONES, Alan Wingate Director 1995-03-29 1995-11-30
KHAN, Usman Director 2021-03-31 2026-02-01
LANDAU, Igor Gilbert Director 2003-03-11 2004-06-30
LANGLOIS, Patrick Director 1996-05-30 2004-06-30
LANKESTER, Robert George Director 1993-07-19
LINAKER, Lawrence Edward Director 1994-07-01 1995-11-30
MCCLELLAN, Michael James Director 2007-11-16 2010-10-01
MITCHUM, James Paul Director 1999-12-16 2002-12-13
MOORE, Daniel Director 2000-04-18 2001-06-09
NICHOLLS, David John Director 1996-10-04 2005-07-01
OLDFIELD, Stephen Philip Director 2010-05-12 2014-07-25
PETERS, David Robert Director 1992-06-30
PLUMB, Charles Henry, Lord Director 1994-12-31
PROSSER, Andrew Michael James Director 2010-09-01 2016-04-01
REDMOND, Michael Director 1993-02-25 1996-03-31
REES, David Hugh Thomas Director 2000-01-10 2005-07-01
RICHARDSON, David Director 1993-12-12 1996-03-29
ROBERTS, David Gardner Director 1993-12-01 1995-11-30
ROTHWELL, Timothy Gordon Director 1995-10-23 1997-11-21
SCROGGS, Cedric Annesley Director 1993-12-12
STENVALL, Tarja Johanna Director 2014-11-19 2016-05-09
STEPHENSON, Jean Philomena Josephine Director 2016-05-09 2018-10-02
THOMAS, Roy Digby Director 1993-12-10
TILLETT, Gordon Michael Director 2021-03-31 2021-08-19
UBHI, Rippondeep Director 2024-03-01 2026-02-01
VISCONTI, Sylvain Emile Director 1995-10-23 1997-11-21
WALLIS, Stuart Michael Director 1994-09-01 1995-11-30

Ownership

Persons with significant control

Name Kind Nature of control Notified Status
Aventis Pharma Limited Corporate entity Shares 75–100%, Voting 75–100%, Appoints directors 2021-01-25 Active
Sanofi-Aventis Uk Holdings Limited Corporate entity Shares 75–100%, Voting 75–100%, Appoints directors 2016-04-06 Ceased 2021-01-25

Filing timeline

Last 20 of 616 total filings

Date Type Category Description
2026-02-05 AP01 officers Appoint person director company with name date PDF
2026-02-04 TM01 officers Termination director company with name termination date PDF
2026-02-04 TM01 officers Termination director company with name termination date PDF
2026-02-04 AP01 officers Appoint person director company with name date PDF
2026-01-05 CS01 confirmation-statement Confirmation statement with no updates PDF
2025-12-12 AA accounts Accounts with accounts type full
2025-05-27 RP04AP01 officers Second filing of director appointment with name PDF
2025-05-19 CH01 officers Change person director company with change date PDF
2025-02-09 CS01 confirmation-statement Confirmation statement with no updates PDF
2024-07-06 AA accounts Accounts with accounts type full
2024-03-03 AP01 officers Appoint person director company with name date
2024-03-01 TM01 officers Termination director company with name termination date PDF
2024-02-02 CS01 confirmation-statement Confirmation statement with no updates PDF
2023-07-18 AA accounts Accounts with accounts type full
2023-01-06 CS01 confirmation-statement Confirmation statement with no updates PDF
2022-07-15 AA accounts Accounts with accounts type full
2022-02-07 CS01 confirmation-statement Confirmation statement with no updates PDF
2021-08-24 AP01 officers Appoint person director company with name date PDF
2021-08-20 TM01 officers Termination director company with name termination date PDF
2021-07-28 AA accounts Accounts with accounts type full

Public-record activity

Raw counts from Companies House — last 12–24 months

Filings
8

last 12 months

Capital events
0

last 24 months

Officers appointed
2

last 12 months

Officers resigned
2

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

Year-on-year

FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers

Official Companies House page